SCHEMBL8445338

SCHEMBL8445338

CCOc1cc(C(=O)OC)c(OC2CCCCO2)c(NS(=O)(=O)c2ccc(OC)cc2)c1Oc1cccc(OC)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.41
LMNA P02545 6/20 0.41
SMN1; SMN2 Q16637 4/20 0.41
HPGD P15428 3/20 0.41
PKM P14618 1/20 0.41
MAPT P10636 3/20 0.40
KDM4E B2RXH2 3/20 0.39
HSD17B10 Q99714 1/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
GAA P10253 2/20 0.39
KMT2A Q03164 2/20 0.39
MEN1 O00255 1/20 0.39
TCF4 P15884 1/20 0.39
CTNNB1 P35222 1/20 0.39
HTT P42858 4/20 0.38
MAPK1 P28482 2/20 0.38
EDNRB P24530 1/20 0.38
EDNRA P25101 1/20 0.38
RCE1 Q9Y256 1/20 0.38
TP53 P04637 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8444252 0.94 EDNRB (0.46) EDNRBEDNRA
SCHEMBL8445313 0.94 EDNRB (0.44) ALDH1A1LMNASMN1; SMN2HPGDPKM
SCHEMBL8441557 0.91 ALDH1A1 (0.42) ALDH1A1LMNASMN1; SMN2HPGDPKM
SCHEMBL8443151 0.90 ALDH1A1 (0.41) ALDH1A1LMNASMN1; SMN2HPGDMAPT
SCHEMBL8441685 0.85 EDNRA (0.46) ALDH1A1LMNASMN1; SMN2HPGDMAPT
SCHEMBL8444251 0.84 NPC1 (0.37) ALDH1A1LMNASMN1; SMN2HPGDMAPT
SCHEMBL8441932 0.84 EDNRA (0.45) EDNRBEDNRA
SCHEMBL8445360 0.84 ALDH1A1 (0.42) ALDH1A1LMNASMN1; SMN2HPGDMAPT
SCHEMBL8441928 0.83 ALDH1A1 (0.36) ALDH1A1LMNASMN1; SMN2HPGDMAPT
SCHEMBL8444952 0.83 LMNA (0.37) ALDH1A1LMNASMN1; SMN2HPGDMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5962682-A Aryl- and hetaryl-sulfonamide derivatives, their preparation and their use as endothelin antagonists HOFFMANN-LA ROCHE INC. (US) 1999-10-05 US disclosed